Park BH - Search Results

1

Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the Horse.

Stearns V, Park BH. Stearns V, et al. Among authors: park bh. JAMA Oncol. 2015 Aug;1(5):569-70. doi: 10.1001/jamaoncol.2015.0761. JAMA Oncol. 2015. PMID: 26182336 No abstract available.

2

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

Jelovac D, Beaver JA, Balukrishna S, Wong HY, Toro PV, Cimino-Mathews A, Argani P, Stearns V, Jacobs L, VanDenBerg D, Kessler J, Jeter S, Park BH, Wolff AC. Jelovac D, et al. Among authors: park bh. Hum Pathol. 2014 Apr;45(4):880-3. doi: 10.1016/j.humpath.2013.10.016. Epub 2013 Oct 31. Hum Pathol. 2014. PMID: 24444464 Free PMC article.

3

PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions.

Stearns V, Park BH. Stearns V, et al. Among authors: park bh. JAMA Oncol. 2018 Oct 1;4(10):1330-1332. doi: 10.1001/jamaoncol.2018.1766. JAMA Oncol. 2018. PMID: 29902310 No abstract available.

4

Pathogenic Germline Variants in Patients With Metastatic Breast Cancer.

Stuttgen K, Croessmann S, Fetting J, Stearns V, Nunes R, Connolly RM, Park BH. Stuttgen K, et al. Among authors: park bh. JAMA Oncol. 2019 Oct 1;5(10):1506-1508. doi: 10.1001/jamaoncol.2019.3116. JAMA Oncol. 2019. PMID: 31465090 Free PMC article.

5

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.

Higgins MJ, Jelovac D, Barnathan E, Blair B, Slater S, Powers P, Zorzi J, Jeter SC, Oliver GR, Fetting J, Emens L, Riley C, Stearns V, Diehl F, Angenendt P, Huang P, Cope L, Argani P, Murphy KM, Bachman KE, Greshock J, Wolff AC, Park BH. Higgins MJ, et al. Among authors: park bh. Clin Cancer Res. 2012 Jun 15;18(12):3462-9. doi: 10.1158/1078-0432.CCR-11-2696. Epub 2012 Mar 15. Clin Cancer Res. 2012. PMID: 22421194 Free PMC article.

6

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

Beaver JA, Jelovac D, Balukrishna S, Cochran R, Croessmann S, Zabransky DJ, Wong HY, Toro PV, Cidado J, Blair BG, Chu D, Burns T, Higgins MJ, Stearns V, Jacobs L, Habibi M, Lange J, Hurley PJ, Lauring J, VanDenBerg D, Kessler J, Jeter S, Samuels ML, Maar D, Cope L, Cimino-Mathews A, Argani P, Wolff AC, Park BH. Beaver JA, et al. Among authors: park bh. Clin Cancer Res. 2014 May 15;20(10):2643-2650. doi: 10.1158/1078-0432.CCR-13-2933. Epub 2014 Feb 6. Clin Cancer Res. 2014. PMID: 24504125 Free PMC article.

7

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.

Parsons HA, Beaver JA, Cimino-Mathews A, Ali SM, Axilbund J, Chu D, Connolly RM, Cochran RL, Croessmann S, Clark TA, Gocke CD, Jeter SC, Kennedy MR, Lauring J, Lee J, Lipson D, Miller VA, Otto GA, Rosner GL, Ross JS, Slater S, Stephens PJ, VanDenBerg DA, Wolff AC, Young LE, Zabransky DJ, Zhang Z, Zorzi J, Stearns V, Park BH. Parsons HA, et al. Among authors: park bh. Clin Cancer Res. 2017 Jan 15;23(2):379-386. doi: 10.1158/1078-0432.CCR-16-1543. Epub 2016 Aug 3. Clin Cancer Res. 2017. PMID: 27489289 Free PMC article.

8

Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J. Dalton WB, et al. Among authors: park bh. JCO Precis Oncol. 2017;2017:PO.16.00046. doi: 10.1200/PO.16.00046. Epub 2017 May 31. JCO Precis Oncol. 2017. PMID: 30003184 Free PMC article.

9

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Connolly RM, Leal JP, Solnes L, Huang CY, Carpenter A, Gaffney K, Abramson V, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Krop IE, Winer EP, Camp M, Miller RS, Wolff AC, Cimino-Mathews A, Park BH, Wahl RL, Stearns V. Connolly RM, et al. Among authors: park bh. J Clin Oncol. 2019 Mar 20;37(9):714-722. doi: 10.1200/JCO.2018.78.7986. Epub 2019 Feb 5. J Clin Oncol. 2019. Retraction in: J Clin Oncol. 2021 Jul 10;39(20):2319. doi: 10.1200/JCO.21.00752 PMID: 30721110 Free PMC article. Retracted. Clinical Trial.

10

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.

Walsh EM, Mangini N, Fetting J, Armstrong D, Chan IS, Connolly RM, Fiallos K, Lehman J, Nunes R, Petry D, Reynolds J, Shah M, Smith KL, Visvanathan K, Lauring J, Park BH, Stearns V, Wolff AC. Walsh EM, et al. Among authors: park bh. Clin Breast Cancer. 2022 Jun;22(4):319-325. doi: 10.1016/j.clbc.2021.12.007. Epub 2021 Dec 30. Clin Breast Cancer. 2022. PMID: 35074264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

984 results

Search Page

Filters